Regeneration Biology: Cancellation of Repurchased Shares, Intended Change in Registered Capital and Business Scope.

Huisheng Bio announced that the company held the fourth meeting of the fourth session of the board of directors to review and approve the proposal to change the registered capital, business scope, and amend the "Articles of Association", which still needs to be submitted for approval at the first extraordinary general meeting of shareholders in 2026. Due to the cancellation of 548,200 shares in the repurchase special account, the total share capital of the company will be reduced from 202.33 million shares to 201.78 million shares, and the registered capital will be reduced from 202.33 million yuan to 201.78 million yuan. In addition, the company plans to add four new businesses within its original business scope, including "daily miscellaneous goods manufacturing."